Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 3.40 0.00%
ACRS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $500.48M
- EPS (TTM)
- -$0.58
- Dividend yield
- None
- 52-week range
- 1.74 – 6.60
- Day range
- 3.32 – 3.60
- Volume / Avg
- 9.00M / 2.36M
- Beta
- —
- Shares outstanding
- 147.20M
- Next earnings
- Nov 5, 2026
52-week range
ACRS stock today
Shares of Aclaris Therapeutics (ACRS) finished lower on Oct 7 at $3.40, a drop of 8.11% or $0.30 per share, versus the S&P 500's 0.22% decline. Volume was 3.8x the average at 9.00M shares, a sign of unusually heavy trading. Shares are 48.5% below their 52-week high of $6.60 and 95.4% above the 52-week low of $1.74, in the middle of the past year's range.
Aclaris Therapeutics has posted a net loss over the last twelve months (EPS of -$0.58), so its P/E ratio is not meaningful. Aclaris Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Aclaris Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2015
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.16
Aclaris Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PHATPhathom Pharmaceuticals Inc. | 6.81 | +0.44% | $550.94M | vs ACRS |
| CTMXCytomX Therapeutics Inc. | 2.55 | -0.39% | $555.64M | vs ACRS |
| BLSMBlossomHill Therapeutics Inc. | 16.61 | -3.93% | $527.95M | vs ACRS |
| MNPRMonopar Therapeutics Inc. | 83.78 | +5.29% | $562.35M | vs ACRS |
| OCSOculis Holding AG | 8.50 | -2.52% | $523.50M | vs ACRS |
| CRMDCorMedix Inc. | 7.28 | 0.00% | $567.43M | vs ACRS |
| STTKShattuck Labs Inc. | 5.66 | -3.50% | $567.55M | vs ACRS |
| MPLTMapLight Therapeutics Inc. | 9.36 | -3.41% | $520.19M | vs ACRS |
Indexes, lists and sector
Largest Health Care stocks
Aclaris Therapeutics stock FAQ
What is Aclaris Therapeutics's stock price today?
ACRS last traded at $3.40 as of Oct 7, 4:00 PM EDT, down 8.11% on the day. Prices are delayed at least 15 minutes.
When is Aclaris Therapeutics's next earnings date?
Aclaris Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.16.
What is the ACRS 52-week high?
The 52-week high for ACRS is $6.60 and the 52-week low is $1.74. The stock is currently 48.5% below its high.